TEST OPTI

The chart shows the growth of an initial investment of $10,000 in TEST OPTI, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends. The portfolio is rebalanced Every 3 months.

Based on dividend-adjusted daily data since Oct 1, 2020, TEST OPTI's average daily return is +0.12%, while the average monthly return is +2.43%. At this rate, an investment would double in approximately 2.4 years.

Historically, 67% of months were positive and 33% were negative. The best month was Nov 2020 with a return of +13.7%, while the worst month was Apr 2022 at -12.8%. The longest winning streak lasted 7 consecutive months, and the longest losing streak was 3 months.

On a daily basis, TEST OPTI closed higher 56% of trading days. The best single day was Apr 9, 2025 with a return of +12.4%, while the worst single day was Apr 4, 2025 at -6.8%.

TEST OPTI has an annualized alpha of 12.59%, beta of 1.23, and R² of 0.75 versus S&P 500 Index. Calculated based on daily prices since October 01, 2020.

• This portfolio captured 154.53% of S&P 500 Index gains but only 90.43% of its losses — a favorable profile for investors.
• This portfolio generated an annualized alpha of 12.59% versus S&P 500 Index — delivering returns beyond what market exposure alone would predict.

TEST OPTI has an expense ratio of 0.12%, which is considered low. Below, you can find the expense ratios of the portfolio's funds side by side and easily compare their relative costs.

TEST OPTI ranks 60 for risk / return — on par with similar portfolios. You're getting a typical balance of risk and reward. Not a standout, but not a red flag either — a reasonable choice if other factors align with your goals.

The Sharpe ratio helps investors understand how much return they're getting for the level of risk taken. A higher Sharpe ratio indicates better risk-adjusted performance, meaning more reward for each unit of risk.

TEST OPTI Sharpe ratios as of Apr 16, 2026 (values are recalculated daily):

• 1-Year: 3.16
• 5-Year: 1.22
• All Time: 1.31

These values reflect how efficiently the investment has delivered returns relative to its volatility over different time periods. All figures are annualized and based on daily total returns (including price changes and dividends).

Compared to the broad market, where average Sharpe ratios range from 2.19 to 3.00, this portfolio's current Sharpe ratio is in the top 25%. This signifies superior risk-adjusted performance, meaning the portfolio is delivering strong returns for the level of risk taken compared to most others.

The chart below shows the rolling Sharpe ratio of TEST OPTI compared to the selected benchmark. This view highlights how the investment's risk-adjusted performance has changed over time.

TEST OPTI provided a 0.54% dividend yield over the last twelve months.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the TEST OPTI. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the TEST OPTI was 40.41%, occurring on Nov 3, 2022. Recovery took 256 trading sessions.

The current TEST OPTI drawdown is 5.14%.

The chart below shows the rolling one-month volatility.